Automated Immunoassay Precision: Scaling Pre-Clinical Throughput with ELLA™ Technology

In the competitive landscape of drug development, reproducibility and data integrity are the bedrock of successful regulatory filings. As part of our commitment to evolving beyond traditional ELISA methodologies, Tetrad Discovery has transitioned to the ELLA™ Simple Plex platform, setting a new benchmark for high-sensitivity bio-analysis.

Traditional immunoassay workflows are notoriously labour-intensive, often plagued by inter-operator variability and long turnaround times. The ELLA™ platform solves these bottlenecks by leveraging microfluidic Simple Plex cartridge technology, where all reagents are pre-loaded within a self-contained, automated environment.

The upgrade has fundamentally changed our throughput capabilities:

• Speed: The platform processes up to 70 samples in approximately 90 minutes, drastically accelerating our client pipelines.

• Sensitivity: Featuring a massive dynamic range and Lower Limits of Quantitation (LLOQ) as low as 1pg/mL, we can now detect analytes previously inaccessible via conventional methods.

• Consistency: The system eliminates manual cross-reactivity and inter-user variability, ensuring clinical-grade reproducibility across every single run.